Penn Medicine - Abramson Cancer Center Perelman — Philadelphia, Pennsylvania

Penn Medicine - Abramson Cancer Center Perelman is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Penn Medicine - Abramson Cancer Center Perelman has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma.

Sponsors: CellCentric Ltd..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Penn Medicine - Abramson Cancer Center Perelman?

Penn Medicine - Abramson Cancer Center Perelman has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Penn Medicine - Abramson Cancer Center Perelman conducted?

Penn Medicine - Abramson Cancer Center Perelman has 1 clinical trials on record, with 1 currently active. Their work covers Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma.

Is Penn Medicine - Abramson Cancer Center Perelman accredited by Crixeo Health?

Penn Medicine - Abramson Cancer Center Perelman has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Penn Medicine - Abramson Cancer Center Perelman?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.